BUFFALO, NY — October 22, 2025 — A new case report was published in Volume 12 of Oncoscience on October 6, 2025, titled “A peculiar case of primary lymphoma of pancreas: A rare presentation of Hodgkin lymphoma.”

Cervical cancer, one of the most preventable yet lethal malignancies among women, continues to threaten lives globally due to unequal access to quality screening and diagnosis.

Corewell Health physicians are researching cancer treatment advancements with a new, nearly $2.2 million grant from the National Institutes of Health. The four-year grant will help doctors potentially bring a type of proton beam technology, called dynamic SPArc (Spot-Scanning Proton Arc), into everyday patient care.

Colorectal cancer is one of the most common tumours among people over the age of 50. Although it is known to develop from small lesions or polyps, its exact causes are unknown — only a few risk factors are known — and it is usually treated with surgery, chemotherapy and radiotherapy, or biological therapies. Now, a study by the University of Barcelona reveals that the combination of palbociclib and telaglenastat, two drugs with complementary actions, could help improve the clinical treatment of this type of cancer, the third most common worldwide.

Researchers at Wake Forest University School of Medicine have developed a groundbreaking, battery-free wearable patch that could help detect skin cancer earlier and more accurately, potentially saving lives by making screening more accessible and less invasive. 

Mathematical modeling is transforming how the world fights cervical cancer. 

New study led by researchers at Cincinnati Children’s proposes a way to combine previously separate data gathering approaches and concepts about blood cell formation into a more unified whole

Researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), have published a landmark review on BH3 mimetics—a new class of drugs that are reshaping the treatment landscape for acute myeloid leukaemia (AML), one of the most aggressive and treatment-resistant blood cancers.